186 related articles for article (PubMed ID: 9105850)
21. Comparative efficacy of fluoroquinolones, aminoglycosides, ureidopenicillins & newer cephalosporins against Pseudomonas species.
Paul K; De PK; Bhattacharya S
Indian J Med Res; 1992 May; 95():136-8. PubMed ID: 1506063
[TBL] [Abstract][Full Text] [Related]
22. [Activity of new quinolones against clinical isolates of Corynebacterium species].
Yagüe Guirao G; Martínez-Toldos MC; Mora Peris B; López Domínguez R; Romero Otero M; Muñoz Bellido JL; Segovia Hernández M
Rev Esp Quimioter; 2000 Sep; 13(3):267-70. PubMed ID: 11086275
[TBL] [Abstract][Full Text] [Related]
23. In vitro activity of tigecycline and 10 other antimicrobials against clinical isolates of the genus Corynebacterium.
Fernandez-Roblas R; Adames H; Martín-de-Hijas NZ; Almeida DG; Gadea I; Esteban J
Int J Antimicrob Agents; 2009 May; 33(5):453-5. PubMed ID: 19153032
[TBL] [Abstract][Full Text] [Related]
24. Urinary pathogens and bacterial sensitivity in hospitalized urological patients based upon clinical aspects.
Naber KG; Bauernfeind A; Dietlein G; Wittenberger R
Scand J Urol Nephrol Suppl; 1987; 104():47-57. PubMed ID: 3501901
[TBL] [Abstract][Full Text] [Related]
25. Infections caused by antibiotic-resistant Corynebacterium group D2.
Soriano F; Fernández-Roblas R
Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):337-41. PubMed ID: 3137032
[TBL] [Abstract][Full Text] [Related]
26. [Case report: a case of hyperammonemia due to obstructive urinary tract infection].
Soeno S; Kenzaka T; Takeda K; Tanaka Y; Kuroki S
Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):976-8. PubMed ID: 23772515
[No Abstract] [Full Text] [Related]
27. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). III. Secular changes in susceptibility].
Kumamoto Y; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Kitagawa R; Igari J; Oguri T; Kosakai N; Yamaguchi K; Kashitani F; Yonezu S; Yamanaka Y; Takaha M; Iori F
Jpn J Antibiot; 1996 Jun; 49(6):555-657. PubMed ID: 8776631
[TBL] [Abstract][Full Text] [Related]
28. [Corynebacterium urealyticum in urinary infections in children].
Coman G; Brumariu O; Petraru E; Cucer F; Muneanu M
Bacteriol Virusol Parazitol Epidemiol; 1998; 43(1-2):47-51. PubMed ID: 9718749
[TBL] [Abstract][Full Text] [Related]
29. [Bacterial flora of urinary tract infections: changes in sensitivity to antibiotics over a 5 year period].
Rocha H; de Oliveira MM
AMB Rev Assoc Med Bras; 1972 Jun; 18(6):203-6. PubMed ID: 4538426
[No Abstract] [Full Text] [Related]
30. USA resistance patterns among UTI pathogens.
Thomson KS; Sanders WE; Sanders CC
J Antimicrob Chemother; 1994 May; 33 Suppl A():9-15. PubMed ID: 7928840
[TBL] [Abstract][Full Text] [Related]
31. Pharmacodynamics of antimicrobial agents and rationale for their dosing.
MacGowan AP; Bowker KE
J Chemother; 1997 May; 9 Suppl 1():64-73. PubMed ID: 9248964
[TBL] [Abstract][Full Text] [Related]
32. [Pneumonia caused by Corynebacterium pseudodiphteriticum, an entity worth knowing].
Aspiroz Sancho C; Agustín Berne A; Navarro Pardos C; Sañudo Blasco B; Teller Justes P
An Med Interna; 2002 Sep; 19(9):463-5. PubMed ID: 12420632
[TBL] [Abstract][Full Text] [Related]
33. Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998).
Gales AC; Jones RN; Gordon KA; Sader HS; Wilke WW; Beach ML; Pfaller MA; Doern GV
J Antimicrob Chemother; 2000 Mar; 45(3):295-303. PubMed ID: 10702547
[TBL] [Abstract][Full Text] [Related]
34. Sepsis due to multiply resistant Corynebacterium amycolatum.
de Miguel-Martinez I; Fernández-Fuertes F; Ramos-Macías A; Bosch-Benitez JM; Martín-Sánchez AM
Eur J Clin Microbiol Infect Dis; 1996 Jul; 15(7):617-8. PubMed ID: 8874085
[No Abstract] [Full Text] [Related]
35. Antibiotic susceptibilities of Parachlamydia acanthamoeba in amoebae.
Maurin M; Bryskier A; Raoult D
Antimicrob Agents Chemother; 2002 Sep; 46(9):3065-7. PubMed ID: 12183273
[TBL] [Abstract][Full Text] [Related]
36. A case of urinary tract infection caused by Corynebacterium urealyticum and coryneform group F1.
Soriano F; Ponte C
Eur J Clin Microbiol Infect Dis; 1992 Jul; 11(7):626-8. PubMed ID: 1396772
[TBL] [Abstract][Full Text] [Related]
37. An encrusted cystitis caused by Corynebacterium urealyticum in a dog.
Gomez A; Nombela C; Zapardiel J; Soriano F
Aust Vet J; 1995 Feb; 72(2):72-3. PubMed ID: 7779042
[No Abstract] [Full Text] [Related]
38. The Brief Case:
Rogovskyy AS; Bailey LK; Blazier JC; Cai JJ; Landis M; Lidbury JA; Pavlova E; Wu J
J Clin Microbiol; 2022 Feb; 60(2):e0045321. PubMed ID: 35170983
[No Abstract] [Full Text] [Related]
39. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
[TBL] [Abstract][Full Text] [Related]
40. In vitro activity of linezolid and 12 other antimicrobials against coryneform bacteria.
Gómez-Garcés JL; Alos JI; Tamayo J
Int J Antimicrob Agents; 2007 Jun; 29(6):688-92. PubMed ID: 17475450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
